Thursday, November 07, 2013 9:33:38 AM
Keep in mind that all details of this transaction are not 100% fully known, however, this is what we do know...... or at least think we know as of now. I will update this post as more information develops.
On August 27, 2013, DNDT acquired all the inventory, other assets and the exclusive rights to distribute a pharmaceutical line of products in the United States, Canada and Europe from Rafarma Pharmaceuticals(OTC:BB RAFA).
http://www.prweb.com/releases/2013/8/prweb11064769.htm
The products were developed at Orenburg State University by Russian scientists, headed by Ramil Rakhmatullin and have both medicinal and cosmetic uses.
In Russia these products go under the name 'Hyamatrix', however, they have been rebranded by DNDT and will now be sold as 'Bioassaygen' in the US, Canada and Europe. At this point we do not know why the products have been rebranded, only that it has been confirmed by DNDT CEO Jon Peters that Hyamatrix is indeed Bioassaygen.
The inventory of products acquired includes Bioassaygen Gel, Bioassaygen Cosmetic Mask, Bioassaygen Bio-Skin, and Bioassaygen Delivery Gel, all of which will henceforth be manufactured and distributed by DNDT under the “Bioassaygen” name. A contract-manufacturer for the product has already been identified in Europe, and sale and distribution arrangements are currently being made in several European countries.
Their flagship product is the Bioassaygen Bio-Skin, a revolutionary skin replacement bandage used to treat burn victims. This product has won numerous awards and has been covered extensively by news agencies throughout Russia and Europe, including CNN.
Russian Website:
http://hyamatrix.ru/
Hungarian Distributors Website:
http://www.hyamatrix.hu/
YouTube Videos:
http://www.youtube.com/user/Hyamatrix/videos
News:
http://www.gbs-europe.com/uploads/editors/bioskinhun.pdf
http://www.slideshare.net/StartupVillage2013/startup-villageppt-23501571
http://www.russianfareastcommercialnews.com/750.pdf
http://marchmontnews.com/Technology-Innovation/Features/18084-Now-production-Hyamatrix-bio-skin-set-improve-lives-and-defy-ageing.html
http://marchmontnews.com/Technology-Innovation/Central-regions/17698-Nanosynthezs-40m-EU-and-US-hi-tech-cosmetics-sales-endorsed.html
http://venturevolga.com/orenburg%E2%80%99s-hyamatrix-bioskin-to-be-tested-in-sklifosovsky-hospital.html
http://en.pharmcluster.ru/2012/08/bioskin-quot-hyamatrix-quot-a-candidate-to-skolkovo-residence-got-a-support-from-vladimir-putin/
http://torchrelay.sochi2014.com/en/news-ramil-rakhmatullin-inventor-of-the-hyamatrix-bioskin-may-take-part-in-the-olympic-torch-relay
http://russia-ic.com/education_science/breakthrough/1086/#.UnkPZRDQtVU
http://voiceofrussia.com/2011/12/06/61664864/
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM